Dilated phase of hypertrophic cardiomyopathy caused by Fabry disease with atrial flutter and ventricular tachycardia

Journal of Cardiology

Volumn 54, Issue 1, 2009, Pages 139-143

  Fukuzawa, Koji ^a   Yoshida, Akihiro ^a   Onishi, Tetsuari ^a   Suzuki, Atsushi ^a   Kanda, Gaku ^a   Takami, Kaoru ^a   Kumagai, Hiroyuki ^a   Torii, Satoko ^a   Takami, Mitsuru ^a   Fukuda, Yuko ^a   Kawai, Hiroya ^a   Hirata, Ken ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial flutter; Cardiac resynchronization therapy with defibrillator; Fabry disease; Hypertrophic cardiomyopathy; Ventricular tachycardia

Indexed keywords

ALPHA GALACTOSIDASE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ATENOLOL; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; IMIDAPRIL;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENZYME ACTIVITY; ENZYME ASSAY; FABRY DISEASE; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HEART PALPITATION; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE;

ATRIAL FLUTTER; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; ELECTRIC COUNTERSHOCK; FABRY DISEASE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR;

EID: 67650744175     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.10.004     Document Type: Article

References (17)

1. Brady R.O., Gal A.E., Bradley R.M., Martensson E., Warshaw A.L., and Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med 276 (1967) 1163-1167
2. Mehta A., Ricci R., Widmer U., Dehout F., Garcia de Lorenzo A., Kampmann C., et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. Eur J Clin Invest 34 (2004) 236-242
3. Linhart A., Palecek T., Bultas J., Ferguson J.J., Hrudová J., Karetová D., et al. New insights in cardiac structural changes in patients with Fabry's disease. Am Heart J 139 (2000) 1101-1108
4. Shah J.S., Lee P., Hughes D., Thaman R., Sachdev B., Pellerin D., et al. The natural history of left ventricular systolic function in Anderson-Fabry disease. Heart 91 (2005) 533-534
5. Shah J.S., Hughes D.A., Sachdev B., Tome M., Ward D., Lee P., et al. Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. Am J Cardiol 96 (2005) 842-846
6. Frustaci A., and Chimenti C. Images in cardiovascular medicine. Cryptogenic ventricular arrhythmias and sudden death by Fabry disease: prominent infiltration of cardiac conduction tissue. Circulation 116 (2007) e350-e351
7. Bax J.J., Bleeker G.B., Marwick T.H., Molhoek S.G., Boersma E., Steendijk P., et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 1834-1840
8. Beck M., Ricci R., Widmer U., Dehout F., de Lorenzo A.G., Kampmann C., et al. Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest 34 (2004) 838-844
9. Schiffmann R., Kopp J.B., Austin III H.A., Sabnis S., Moore D.F., Weibel T., et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285 (2001) 2743-2749
10. Nakao S., Takenaka T., Maeda M., Kodama C., Tanaka A., Tahara M., et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 333 (1995) 288-293
11. Sachdev B., Takenaka T., Teraguchi H., Tei C., Lee P., McKenna W.J., et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105 (2002) 1407-1411
12. Chimenti C., Pieroni M., Morgante E., Antuzzi D., Russo A., Russo M.A., et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation 110 (2004) 1047-1053
13. Takenaka T., Teraguchi H., Yoshida A., Taguchi S., Ninomiya K., Umekita Y., et al. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol 51 (2008) 50-59
14. Jansen A.H., van Dantzig J., Bracke F., Peels K.H., Koolen J.J., Meijer A., et al. Improvement in diastolic function and left ventricular filling pressure induced by cardiac resynchronization therapy. Am Heart J 153 (2007) 843-849
15. Penicka M., Bartunek J., De Bruyne B., Vanderheyden M., Goethals M., De Zutter M., et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 109 (2004) 978-983
16. Pieroni M., Chimenti C., De Cobelli F., Morgante E., Del Maschio A., Gaudio C., et al. Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol 47 (2006) 1663-1671
17. Pieroni M., Chimenti C., Ricci R., Sale P., Russo M.A., and Frustaci A. Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 107 (2003) 1978-1984